These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1383063)

  • 21. HIV resistance to reverse transcriptase inhibitors.
    De Clercq E
    Biochem Pharmacol; 1994 Jan; 47(2):155-69. PubMed ID: 7508227
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential inhibitory effects of TIBO derivatives on different strains of simian immunodeficiency virus.
    Debyser Z; De Vreese K; Pauwels R; Yamamoto N; Anné J; De Clercq E; Desmyter J
    J Gen Virol; 1992 Jul; 73 ( Pt 7)():1799-804. PubMed ID: 1378481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific HIV-1 reverse transcriptase inhibitors.
    Debyser Z; Pauwels R; Andries K; De Clercq E
    J Enzyme Inhib; 1992; 6(1):47-53. PubMed ID: 1285302
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-on e (TIBO) derivatives. 2.
    Kukla MJ; Breslin HJ; Diamond CJ; Grous PP; Ho CY; Miranda M; Rodgers JD; Sherrill RG; De Clercq E; Pauwels R
    J Med Chem; 1991 Nov; 34(11):3187-97. PubMed ID: 1956037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-aminoimidazole derivatives inhibiting retroviral replication via a yet unidentified mode of action.
    Lagoja IM; Pannecouque C; Van Aerschot A; Witvrouw M; Debyser Z; Balzarini J; Herdewijn P; De Clercq E
    J Med Chem; 2003 Apr; 46(8):1546-53. PubMed ID: 12672256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors.
    Buckheit RW; Fliakas-Boltz V; Decker WD; Roberson JL; Pyle CA; White EL; Bowdon BJ; McMahon JB; Boyd MR; Bader JP
    Antiviral Res; 1994 Sep; 25(1):43-56. PubMed ID: 7529014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors.
    Spence RA; Kati WM; Anderson KS; Johnson KA
    Science; 1995 Feb; 267(5200):988-93. PubMed ID: 7532321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent and specific inhibition of human immunodeficiency virus type 1 replication by 4-(2,6-dichlorophenyl)-1,2,5-thiadiazol-3-Y1 N,N-dialkylcarbamate derivatives.
    Ijichi K; Fujiwara M; Hanasaki Y; Watanabe H; Katsuura K; Takayama H; Shirakawa S; Sakai S; Shigeta S; Konno K
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2337-40. PubMed ID: 8619592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a thiobenzimidazolone derivative on DNA strand transfer catalyzed by HIV-1 reverse transcriptase.
    Gopalakrishnan V; Benkovic S
    J Biol Chem; 1994 Feb; 269(6):4110-5. PubMed ID: 7508439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines.
    Livermore DG; Bethell RC; Cammack N; Hancock AP; Hann MM; Green DV; Lamont RB; Noble SA; Orr DC; Payne JJ
    J Med Chem; 1993 Nov; 36(24):3784-94. PubMed ID: 7504733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    McMahon JB; Gulakowski RJ; Weislow OS; Schultz RJ; Narayanan VL; Clanton DJ; Pedemonte R; Wassmundt FW; Buckheit RW; Decker WD
    Antimicrob Agents Chemother; 1993 Apr; 37(4):754-60. PubMed ID: 7684215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to overcome resistance of HIV-1 to HIV-1-specific reverse transcriptase inhibitors.
    De Clercq E
    AIDS; 1994 Jul; 8(7):1020-1. PubMed ID: 7524543
    [No Abstract]   [Full Text] [Related]  

  • 33. HIV-1-specific RT inhibitors: highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase.
    De Clercq E
    Med Res Rev; 1993 May; 13(3):229-58. PubMed ID: 7683360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allosteric inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione compounds.
    Debyser Z; Pauwels R; Andries K; Desmyter J; Engelborghs Y; Janssen PA; De Clercq E
    Mol Pharmacol; 1992 Jan; 41(1):203-8. PubMed ID: 1370707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates.
    White EL; Buckheit RW; Ross LJ; Germany JM; Andries K; Pauwels R; Janssen PA; Shannon WM; Chirigos MA
    Antiviral Res; 1991 Oct; 16(3):257-66. PubMed ID: 1725247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
    Merluzzi VJ; Hargrave KD; Labadia M; Grozinger K; Skoog M; Wu JC; Shih CK; Eckner K; Hattox S; Adams J
    Science; 1990 Dec; 250(4986):1411-3. PubMed ID: 1701568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The synthesis of nucleoside 5'-O-(1,1-dithiotriphosphates).
    Okruszek A; Olesiak M; Balzarini J
    J Med Chem; 1994 Oct; 37(22):3850-4. PubMed ID: 7525960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.
    Kashman Y; Gustafson KR; Fuller RW; Cardellina JH; McMahon JB; Currens MJ; Buckheit RW; Hughes SH; Cragg GM; Boyd MR
    J Med Chem; 1992 Jul; 35(15):2735-43. PubMed ID: 1379639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative structure-activity relationships and comparative molecular field analysis of TIBO derivatised HIV-1 reverse transcriptase inhibitors.
    Hannongbua S; Pungpo P; Limtrakul J; Wolschann P
    J Comput Aided Mol Des; 1999 Nov; 13(6):563-77. PubMed ID: 10584215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors.
    Emini EA; Byrnes VW; Condra JH; Schleif WA; Sardana VV
    Arch Virol Suppl; 1994; 9():11-7. PubMed ID: 7518271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.